The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to PT001, an investigational treatment for pulmonary arterial…
Articles by Marisa Wexler, MS
A new metric for assessing cardiac health, called pulmonary artery proportional pulse pressure or PAPP, could help to identify people…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Sandoz‘s generic treprostinil injection now is available for subcutaneous (under-the-skin) administration to treat pulmonary arterial hypertension (PAH), the…
A new analysis suggests that the doses of rodatristat ethyl — an investigational therapy for pulmonary arterial hypertension…
An updated application has been filed with the U.S. Food and Drug Administration (FDA), again asking that LIQ861Â be approved…
By screening thousands of potential candidates, researchers have identified a compound, called AG1296, that may be useful for the treatment of…
Activation of a protein called aryl hydrocarbon receptor (AHR) is essential for the development of pulmonary arterial hypertension (PAH),…
Treatment with a fungus called Ophiocordyceps sinensis eased disease signs and improved survival in a rat model of pulmonary…
Treatment with the investigational medication levosimendan was found to improve exercise tolerance, and some parameters related to heart function, in…
Experts will discuss how the COVID-19 pandemic has affected people living with pulmonary hypertension and other rare respiratory…
Acute pulmonary hypertension (aPH) is frequent and linked with a higher risk of mortality in people who are severely ill…